XML 67 R52.htm IDEA: XBRL DOCUMENT v3.10.0.1
Share-Based Compensation and Capital Stock (Tables)
12 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Weighted Average Assumptions of Black-Scholes Option-Pricing Model
The fair value of the options granted was estimated on the grant date using the Black-Scholes option-pricing model with the following weighted average assumptions:
 
 
2018
 
2017
 
2016
Risk-free interest rate
2.58
%
 
1.76
%
 
1.22
%
Expected volatility
21.17
%
 
21.64
%
 
23.76
%
Expected life of stock option
4.6 years

 
4.6 years

 
4.6 years

Dividend yield
1.05
%
 
1.42
%
 
1.59
%
Requisite service period
4 years

 
4 years

 
4 years

Contractual life
7 years

 
7 years

 
7 years

Weighted average fair value of options granted (per option)
$
16.27

 
$
10.81

 
$
9.30

Schedule of Options Outstanding and Exercisable
The following table summarizes information about stock options outstanding at December 31, 2018:
 
 
 
Options Outstanding
 
Options Exercisable
Range of Exercise Prices
 
Number Outstanding at December 31, 2018
 
Weighted Average
Remaining
Contractual Life
 
Weighted
Average
Exercise Price
 
Number Exercisable at December 31, 2018
 
Weighted
Average
Exercise Price
$34.13 to $39.00
 
52,664

 
1.1 years
 
$
36.76

 
52,664

 
$
36.76

$39.01 to $48.75
 
417,591

 
2.2 years
 
$
45.59

 
417,591

 
$
45.59

$48.76 to $65.00
 
610,415

 
4.0 years
 
$
56.73

 
283,426

 
$
57.77

$65.01 to $81.55
 
105,510

 
6.2 years
 
$
81.55

 

 
$

 
 
1,186,180

 
3.5 years
 
$
54.13

 
753,681

 
$
49.55

Summary of Activity Related to Restricted Stock Grants
The following table is a summary of activity related to restricted stock grants:
 
For the Year Ended December 31,
 
2018
 
2017
 
2016
Restricted shares granted
101,325

 
175,644

 
204,333

Weighted average grant date fair value per share
$
81.21

 
$
61.84

 
$
51.53

Aggregate grant date fair value ($000)
$
8,229

 
$
10,862

 
$
10,529

Restricted shares forfeited
46,785

 
30,375

 
28,996

Vesting service period of shares granted
12 - 48 months

 
12 - 48 months

 
12 - 48 months

Fair value of shares vested ($000)
$
8,025

 
$
12,616

 
$
7,506

Summary of Activity Related to PVRSU Grants
The following table is a summary of activity related to PVRSU grants:
 
For the Years Ended December 31,
 
2018
 
2017
 
2016
Performance vested restricted stock units granted at target
100,919

 
162,523

 
89,944

Weighted average grant date fair value per share
$
81.25

 
$
60.63

 
$
47.85

Aggregate grant date fair value ($000)
$
8,200

 
$
9,853

 
$
4,304

Stock units forfeited
27,255

 
74,734

 
54,556

Requisite service period
36 - 39 months

 
30 - 36 months

 
9 - 43 months

Summary of Change in Stock-Based Award Activity
A summary of stock-based award activity as of December 31, 2018, 2017 and 2016 and the changes during the years are presented below:
 
2018
 
Stock Options
 
Restricted Stock
 
Performance Vested
Restricted Stock Units
 
Options
 
Weighted Average Exercise Price
 
Weighted
Average
Remaining Contractual
Life
 
Shares
 
Weighted
Average Grant
Date Fair Value
 
Shares
 
Weighted
Average Grant
Date Fair Value
Outstanding at January 1, 2018
1,976,326

 
$
50.80

 
 
 
348,876

 
$
57.05

 
294,204

 
$
56.95

Granted
109,045

 
$
81.55

 
 
 
101,325

 
$
81.21

 
100,919

 
$
81.25

Exercised/Vested
(832,809
)
 
$
49.66

 
 
 
(99,651
)
 
$
55.64

 
(31,048
)
 
$
60.60

Expired
(2,018
)
 
$
63.47

 
 
 

 
$

 

 
$

Forfeited
(64,364
)
 
$
55.79

 
 
 
(46,785
)
 
$
60.40

 
(27,255
)
 
$
64.49

Outstanding at December 31, 2018
1,186,180

 
$
54.13

 
3.5 years
 
303,765

 
$
65.06

 
336,820

 
$
63.28

Options exercisable at December 31, 2018
753,681

 
$
49.55

 
2.7 years
 
 
 
 
 
 
 
 


 
2017
 
Stock Options
 
Restricted Stock
 
Performance Vested
Restricted Stock Units
 
Options
 
Weighted Average Exercise Price
 
Weighted
Average
Remaining Contractual
Life
 
Shares
 
Weighted
Average Grant
Date Fair Value
 
Shares
 
Weighted
Average Grant
Date Fair Value
Outstanding at January 1, 2017
2,193,502

 
$
48.26

 
 
 
407,812

 
$
50.61

 
235,980

 
$
47.59

Granted
195,652

 
$
60.70

 
 
 
175,644

 
$
61.84

 
162,523

 
$
60.63

Performance-Based Leveraging*

 
$

 
 
 

 
$

 
9,491

 
$
45.59

Exercised/Vested
(353,744
)
 
$
39.88

 
 
 
(204,205
)
 
$
48.61

 
(39,056
)
 
$
46.22

Expired
(10,133
)
 
$
56.95

 
 
 

 
$

 

 
$

Forfeited
(48,951
)
 
$
54.12

 
 
 
(30,375
)
 
$
55.02

 
(74,734
)
 
$
39.59

Outstanding at December 31, 2017
1,976,326

 
$
50.80

 
4.1 years
 
348,876

 
$
57.05

 
294,204

 
$
56.95

Options exercisable at December 31, 2017
1,279,500

 
$
48.76

 
3.7 years
 
 
 
 
 
 
 
 
* PVRSU units outstanding have been increased by 9,491 units during the year ended December 31, 2017, due to the Company exceeding the targeted performance conditions contained in PVRSU's granted in prior periods.


 
2016
 
Stock Options
 
Restricted Stock
 
Performance Vested
Restricted Stock Units
 
Options
 
Weighted Average Exercise Price
 
Weighted
Average
Remaining Contractual
Life
 
Shares
 
Weighted
Average Grant
Date Fair Value
 
Shares
 
Weighted
Average Grant
Date Fair Value
Outstanding at January 1, 2016
2,084,201

 
$
41.36

 
 
 
384,490

 
$
47.40

 
226,737

 
$
45.09

Granted
745,769

 
$
51.49

 
 
 
204,333

 
$
51.53

 
89,944

 
$
47.85

Performance-Based Leveraging*

 
$

 
 
 

 
$

 
2,043

 
$
36.76

Exercised/Vested
(529,210
)
 
$
24.47

 
 
 
(152,015
)
 
$
43.61

 
(28,188
)
 
$
36.76

Expired
(13,620
)
 
$
57.62

 
 
 

 
$

 

 
$

Forfeited
(93,638
)
 
$
53.63

 
 
 
(28,996
)
 
$
51.22

 
(54,556
)
 
$
42.82

Outstanding at December 31, 2016
2,193,502

 
$
48.26

 
4.6 years
 
407,812

 
$
50.61

 
235,980

 
$
47.59

Options exercisable at December 31, 2016
816,969

 
$
40.75

 
3.3 years
 
 
 
 
 
 
 
 

* PVRSU units outstanding have been increased by 2,043 units during the year ended December 31, 2016, due to the Company exceeding the targeted performance conditions contained in PVRSU's granted in prior periods.
Pre-Tax Stock-Based Compensation Expenses and Associated Income Tax Benefits
The components of the Company’s pretax stock-based compensation expense and associated income tax benefits are as follows:
 
For the Year Ended December 31,
(In millions)
2018
 
2017
 
2016
Stock options
$
2.4

 
$
9.2

 
$
4.6

Restricted stock
6.8

 
9.0

 
7.5

Performance vested restricted stock units
5.8

 
6.7

 
2.5

Total
$
15.0

 
$
24.9

 
$
14.6

Income tax benefits
$
3.6

 
$
9.2

 
$
5.4

Schedule of Unrecognized Compensation Cost, Nonvested Awards
The total unrecognized compensation costs related to stock-based awards that have not yet vested and the related weighted average amortization period over which the costs are to be recognized as of December 31, 2018 are as follows:
 
Unrecognized Compensation Expense on Unvested Awards
 
Weighted Average Remaining Amortization Period
 
(in millions)
 
 
Stock options
$
3.0

 
2.2 years
Restricted stock
12.6

 
2.3 years
Performance vested restricted stock units
8.9

 
1.8 years
Total
$
24.5